| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| mycophenolate mofetil | Capsule | 250 mg | Current | Unavailable | Manufacturing | 21/06/2024 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 21/06/2024 |
| donepezil hydrochloride | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 21/06/2024 |
| perindopril erbumine | Tablet | 8 mg | Current | Limited Availability | Manufacturing | 21/06/2024 |
| esomeprazole magnesium dihydrate | Tablet, enteric coated | 21.75 mg | Anticipated | Available | Manufacturing | 21/06/2024 |
| Abatacept | Injection | 125.875 mg | Current | Unavailable | Manufacturing | 21/06/2024 |
| fluoxetine hydrochloride | Capsule, hard | 22.35 mg | Resolved | Available | Manufacturing | 21/06/2024 |
| teriflunomide | Tablet, film coated | 14 mg | Resolved | Available | Manufacturing | 21/06/2024 |
| fingolimod hydrochloride | Capsule | 560 microgram | Resolved | Available | Manufacturing | 21/06/2024 |
| bendamustine hydrochloride monohydrate | Injection, powder for | 25 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 21/06/2024 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Limited Availability | Manufacturing | 21/06/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 26.22 mg/mL | Current | Unavailable | Manufacturing | 21/06/2024 |
| paracetamol | Tablet, modified release | 665 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 21/06/2024 |
| carbachol | Injection, solution | 100 microgram/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 21/06/2024 |
| clindamycin phosphate | Injection, solution | 0 QS | Current | Limited Availability | Manufacturing | 21/06/2024 |
| fluoxetine hydrochloride | Capsule, hard | 22.36 mg | Current | Limited Availability | Manufacturing | 21/06/2024 |
| zopiclone | Tablet, film coated | 7.5 mg | Current | Unavailable | Manufacturing | 21/06/2024 |
| lisinopril dihydrate | Tablet | 10.89 mg | Resolved | Available | Manufacturing | 20/06/2024 |
| formoterol fumarate dihydrate~budesonide | Inhalation, pressurised | 2.25 microgram~40 microgram | Discontinued | Unavailable | Commercial Changes / Commercial viability | 20/06/2024 |
| midazolam | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 20/06/2024 |
| vincristine sulfate | Injection, solution | 1 mg/mL | Resolved | Available | Manufacturing | 20/06/2024 |
| Somatropin | Injection, powder for | 12 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 20/06/2024 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Anticipated | Available | Manufacturing | 20/06/2024 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Anticipated | Available | Manufacturing | 20/06/2024 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Limited Availability | Manufacturing | 20/06/2024 |
| methotrexate | Injection, solution | 100 mg/mL | Resolved | Available | Manufacturing | 20/06/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 20/06/2024 |
| felypressin~prilocaine hydrochloride | Injection, solution | .54 microgram/mL~30 mg/mL | Current | Unavailable | Manufacturing | 20/06/2024 |
| prochlorperazine mesilate | Injection, solution | 12.5 mg/mL | Resolved | Available | Manufacturing | 20/06/2024 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 1.819 mg | Anticipated | Available | Manufacturing | 20/06/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 20.681 mg~10 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 20/06/2024 |
| chloramphenicol | Eye Drops | 5 mg/mL | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 20/06/2024 |
| metoprolol tartrate | Tablet, uncoated | 100 mg | Resolved | Available | Manufacturing | 20/06/2024 |
| indometacin | Capsule, hard | 25 mg | Anticipated | Available | Manufacturing | 20/06/2024 |
| naproxen | Tablet, uncoated | 250 mg | Current | Unavailable | Manufacturing | 20/06/2024 |
| dobutamine hydrochloride | Injection, solution | 14.01 mg/mL | Anticipated | Available | Manufacturing | 20/06/2024 |
| estradiol hemihydrate | Drug delivery system, transdermal | 1.54 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 20/06/2024 |
| estradiol hemihydrate | Drug delivery system, transdermal | .77 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 20/06/2024 |
| estradiol hemihydrate | Drug delivery system, transdermal | 3.09 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 20/06/2024 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Anticipated | Available | Manufacturing | 20/06/2024 |
| estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 20/06/2024 |
| clarithromycin | Tablet, film coated | 250 mg | Current | Unavailable | Unexpected increase in consumer demand | 20/06/2024 |
| alendronate sodium | Tablet | 91.37 mg | Current | Unavailable | Manufacturing | 19/06/2024 |
| remifentanil hydrochloride | Injection, powder for | 1.097 mg | Current | Unavailable | Manufacturing | 19/06/2024 |
| telmisartan~hydrochlorothiazide | Tablet, film coated | 80 mg~12.5 mg | Resolved | Available | Manufacturing | 19/06/2024 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Manufacturing | 19/06/2024 |
| irbesartan | Tablet, film coated | 300 mg | Current | Limited Availability | Manufacturing | 19/06/2024 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Current | Unavailable | Commercial Changes / Commercial viability | 19/06/2024 |
| gliclazide | Tablet, modified release | 30 mg | Current | Unavailable | Unexpected increase in consumer demand | 19/06/2024 |
| lacosamide | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 19/06/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 2.7 mg~.62 mg~.78 mg | Current | Unavailable | Manufacturing | 19/06/2024 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Limited Availability | Manufacturing | 19/06/2024 |
| flecainide acetate | Tablet | 50 mg | Current | Limited Availability | Manufacturing | 19/06/2024 |
| rifampicin | Capsule, hard | 300 mg | Current | Unavailable | Manufacturing | 19/06/2024 |
| doxycycline hyclate | Tablet, film coated | 115 mg | Resolved | Available | Manufacturing | 19/06/2024 |
| estradiol~norethisterone acetate | Drug delivery system, transdermal | .62 mg~2.7 mg | Current | Limited Availability | Manufacturing | 19/06/2024 |
| mirtazapine | Tablet, film coated | 30 mg | Resolved | Available | Manufacturing | 19/06/2024 |
| lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate | Injection, solution | 21.3 mg/mL~22.7 microgram/mL | Current | Unavailable | Manufacturing | 18/06/2024 |
| warfarin sodium | Tablet, uncoated | 5 mg | Resolved | Available | Manufacturing | 18/06/2024 |
| methotrexate | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 18/06/2024 |
| griseofulvin | Tablet | 500 mg | Current | Unavailable | Manufacturing | 18/06/2024 |
| vecuronium bromide | Injection, powder for | 10 mg | Anticipated | Available | Unexpected increase in consumer demand | 18/06/2024 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Current | Unavailable | Manufacturing | 18/06/2024 |
| quetiapine fumarate | Tablet, film coated | 28.78 mg | Current | Limited Availability | Manufacturing | 18/06/2024 |
| vecuronium bromide | Injection, powder for | 10 mg | Current | Unavailable | Manufacturing | 18/06/2024 |
| cyclopentolate hydrochloride | Eye Drops, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 18/06/2024 |
| ganciclovir sodium | Injection, powder for | 546 mg | Resolved | Available | Manufacturing | 18/06/2024 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 18/06/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 4.8 mg~.78 mg~.512 mg | Current | Unavailable | Manufacturing | 18/06/2024 |
| proguanil hydrochloride~atovaquone | Tablet, film coated | 25 mg~62.5 mg | Current | Unavailable | Manufacturing | 18/06/2024 |
| sugammadex sodium | Injection | 217.6 mg | Current | Unavailable | Manufacturing | 18/06/2024 |
| insulin | Injection, suspension | 100 IU/mL | Current | Limited Availability | Manufacturing | 18/06/2024 |
| medroxyprogesterone acetate | Injection, suspension | 150 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 18/06/2024 |
| lidocaine hydrochloride monohydrate | Injection, solution | 20 mg/mL | Resolved | Available | Manufacturing | 18/06/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 52.45 mg/mL | Resolved | Available | Manufacturing | 18/06/2024 |
| doxorubicin hydrochloride | Injection, concentrated | 2 mg/mL | Current | Limited Availability | Manufacturing | 18/06/2024 |
| balsalazide sodium | Capsule | 750 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 18/06/2024 |
| ciprofloxacin~hydrocortisone | Ear Drops, suspension | 2 mg/mL~10 mg/mL | Resolved | Available | Manufacturing | 17/06/2024 |
| hydrocortisone sodium succinate | Injection, powder for | 134 mg | Anticipated | Available | Manufacturing | 17/06/2024 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Manufacturing | 17/06/2024 |
| bortezomib | Injection, powder for | 3.5 mg | Resolved | Available | Manufacturing | 17/06/2024 |
| cisatracurium besilate | Injection, solution | 201 mg | Current | Unavailable | Manufacturing | 17/06/2024 |
| rosuvastatin calcium | Tablet, film coated | 10.42 mg | Resolved | Available | Manufacturing | 17/06/2024 |
| olmesartan medoxomil | Tablet | 40 mg | Resolved | Available | Unexpected increase in consumer demand | 17/06/2024 |
| pregabalin | Capsule, hard | 150 mg | Resolved | Available | Manufacturing | 17/06/2024 |
| lisdexamfetamine dimesilate | Capsule, hard | 20 mg | Current | Limited Availability | Unexpected increase in consumer demand | 17/06/2024 |
| lisdexamfetamine dimesilate | Capsule, hard | 60 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/06/2024 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Current | Unavailable | Manufacturing | 17/06/2024 |
| betahistine dihydrochloride | Tablet | 16 mg | Current | Unavailable | Unexpected increase in consumer demand | 17/06/2024 |
| tretinoin | Capsule, soft | 10 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/06/2024 |
| aciclovir | Injection, solution | 25 mg/mL | Current | Limited Availability | Manufacturing | 17/06/2024 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Resolved | Available | Manufacturing | 17/06/2024 |
| amoxicillin trihydrate | Oral Liquid, powder for | 114.82 mg/mL | Resolved | Available | Manufacturing | 17/06/2024 |
2024年6月24日